Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.195
-0.045 (-1.06%)
At close: Feb 17, 2026, 4:00 PM EST
4.200
+0.005 (0.12%)
After-hours: Feb 17, 2026, 4:10 PM EST

Cytek Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
5368361,2361,3772,182-
Market Cap Growth
-26.43%-32.38%-10.21%-36.91%--
Enterprise Value
3085739631,0511,806-
Last Close Price
4.246.499.1210.2116.32-
PE Ratio
---534.4941969.36-
Forward PE
-26.14-44.39152.95-
PS Ratio
2.764.176.418.3917.06-
PB Ratio
1.432.113.153.245.38-
P/TBV Ratio
1.582.333.493.355.59-
P/FCF Ratio
-38.251952.94-8204.54-
P/OCF Ratio
-32.94234.09-471.36-
EV/Sales Ratio
1.562.864.996.4114.12-
EV/EBITDA Ratio
---1527.81173.67-
EV/EBIT Ratio
----197.22-
EV/FCF Ratio
-26.211522.10-6789.29-
Debt / Equity Ratio
0.070.040.040.04-0.02
Debt / EBITDA Ratio
---4.23-0.19
Debt / FCF Ratio
-0.7822.33--0.20
Net Debt / Equity Ratio
-0.63-0.66-0.63-0.76-0.90-0.91
Net Debt / EBITDA Ratio
8.8216.3911.39-469.56-35.06-11.39
Net Debt / FCF Ratio
40.19-11.94-392.2214.70-1370.74-11.94
Asset Turnover
0.400.400.380.330.380.64
Inventory Turnover
1.861.701.521.551.761.96
Quick Ratio
4.305.005.677.9911.886.91
Current Ratio
5.175.866.979.2613.017.86
Return on Equity (ROE)
-3.36%-1.53%-2.97%0.60%1.04%18.38%
Return on Assets (ROA)
-4.36%-2.91%-3.43%-0.23%1.68%5.88%
Return on Invested Capital (ROIC)
-24.50%-16.54%-22.52%-2.24%16.50%127.45%
Return on Capital Employed (ROCE)
-8.20%-5.40%-6.40%-0.40%2.10%7.10%
Earnings Yield
-2.35%-0.72%-0.98%0.19%0.14%-
FCF Yield
-1.08%2.61%0.05%-1.60%0.01%-
Buyback Yield / Dilution
2.85%3.45%2.37%-69.93%-150.13%-16.71%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q